Using MRI to detect bleeding in plaques for stroke diagnosis
Official title: Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage
Run by Ludwig-Maximilians - University of Munich · NCT06749106 · Data updated 2026-11-12
This study is trying to see if using MRI to find bleeding in artery plaques can help doctors better diagnose strokes, especially in patients who have unexplained strokes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Ludwig-Maximilians - University of Munich Academic / other |
| Locations | 1 site (Munich) |
| Status | Recruiting |
| Started | January 16, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | January 24, 2025 |
| Trial ID | NCT06749106 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with acute ischemic stroke who have undergone non-contrast carotid MRI as part of their routine diagnostic work-up.
✕Probably not a fit
Patients with posterior circulation infarcts, bilateral ischemic infarcts, or those who have had prior carotid interventions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the relationship between intraplaque hemorrhage (IPH) detected by non-contrast MRI of the carotid artery and acute ischemic stroke events. By analyzing both prospective and retrospective data, the study seeks to determine if identifying IPH can enhance the diagnostic process for stroke patients, particularly those with cryptogenic strokes. The research focuses on integrating simpler imaging protocols into routine clinical practice to better stratify stroke etiology and identify patients at risk for recurrent strokes.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and targeted treatment for patients experiencing acute ischemic strokes.
How similar studies have gone: Previous studies have indicated that imaging features related to plaque vulnerability can be associated with stroke events, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with acute ischemic stroke * Availability of non-contrast carotid MRI scans obtained through routine diagnostic work-up Exclusion Criteria: * Infarct in the posterior circulation or bilateral ischemic infarcts * Time between symptom onset and non-contrast carotid MRI \> 10 days * Prior stenting of a carotid artery or carotid endarterectomy * Age \< 18 years * Life expectancy \< 1 year * Inability to provide written informed consent This eligibility criteria apply for the prospective part of the PARADE study.
Where it's running
-
Institute for Stroke and Dementia Research
Munich, Germany Recruiting
Study contacts
- Principal investigator: Anna Kopczak, MD — Institute for Stroke and Dementia Research
- Study coordinator: Martin Dichgans, Prof.
- Email: isd@med.uni-muenchen.de
- Phone: +49 89 4400 46019
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Short-Term outside-in nerve stimulation for acute ischemic stroke
This trial tests whether a 5-day external trigeminal nerve stimulation given after stroke can help more patients recover better than a sham treatment.
-
Sevoflurane vs. Propofol for anesthesia in stroke patients undergoing clot-removal
This study tests whether sevoflurane or propofol used for anesthesia during endovascular treatment of an acute ischemic stroke affects the final brain damage and recovery.
-
Safety of adding NRICM301 to standard care for adults with acute ischemic stroke
This study tests whether adding NRICM301, a traditional Chinese medicine formula, to usual care is safe for adults with acute ischemic stroke.
-
Intracranial Recanalization with LT3001 in Acute Ischemic Stroke
This phase II study tests whether LT3001 given to adults with acute ischemic stroke can help reopen blocked brain arteries.
-
Mobilisation After Endovascular Stroke Treatment
This study checks whether moving around 12 hours after endovascular stroke treatment is as safe as moving around 24 hours for people with an acute ischemic stroke.
-
Endovascular therapy plus standard care vs standard care alone for distal and medium vessel strokes
In people with acute ischemic stroke due to distal or medium vessel blockages, this study tests whether adding endovascular treatment to the usual medical care helps improve outcomes compared with medical care alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.